Lipid-based microtubular drug delivery vehicles

Journal of Controlled Release

Volumn 71, Issue 1, 2001, Pages 141-152

  Meilander, Nancy J ^a   Yu, Xiaojun ^a   Ziats, Nicholas P ^a   Bellamkonda, Ravi V ^a  

^a Case Western Reserve University   (United States)

Author keywords

NGF bioassay; Protein delivery; Rodent implantation model; Self assembly; Sustained release

Indexed keywords

AGAROSE; ALBUMIN; DRUG VEHICLE; LIPID; MYOGLOBIN; THYROGLOBULIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BIOCOMPATIBILITY; CATTLE; CELL STRAIN; CONTROLLED STUDY; CYTOTOXICITY; DRUG DELIVERY SYSTEM; FEMALE; HUMAN; HUMAN CELL; HYDROGEL; IMPLANTATION; INFLAMMATION; MICROTUBULE; MOLECULAR WEIGHT; NONHUMAN; PRIORITY JOURNAL; PROTEIN SECRETION; RAT; SMOOTH MUSCLE FIBER; SUSTAINED DRUG RELEASE;

ANIMALS; COCULTURE TECHNIQUES; DRUG DELIVERY SYSTEMS; FEMALE; HUMANS; HYDROGELS; LIPIDS; MATERIALS TESTING; MICROTUBULES; MOLECULAR WEIGHT; PC12 CELLS; RATS; RATS, SPRAGUE-DAWLEY; VEHICLES;

EID: 0035848423     PISSN: 01683659     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-3659(01)00214-0     Document Type: Article

References (35)

1. Liposomes. Opportunities in drug delivery
2. Liposomes in drug delivery. Clinical, diagnostic and ophthalmic potential
3. Efficacy of oral cochleate-amphotericin B in a mouse model of systemic candidiasis
4. Polymers for the controlled release of macromolecules: Effect of molecular weight of ethylene-vinyl acetate copolymer
5. Controlled antibody delivery systems
6. Ethylene-vinyl acetate copolymer microspheres for controlled release of macromolecules
7. Protein delivery from biodegradable microspheres
8. Bioabsorbable polymers for implantable therapeutic systems
9. Effect of controlled adventitial heparin delivery on smooth muscle cell proliferation following endothelial injury
10. Inhibition of smooth muscle cell growth in vitro by an antisense oligodeoxynucleotide released from poly(DL-lactic-co-glycolic acid) microparticles
11. Protein delivery from nondegradable polymer matrices
12. Technical and regulatory hurdles in delivery aspects of macromolecular drugs
13. Stabilization of dichloromethane-induced protein denaturation during microencapsulation
14. Characterization of a partially denatured state of a protein by two-dimensional NMR: Reduction of the hydrophobic interactions in ubiquitin
15. Effects of organic solvents on protein structures: Observation of a structured helical core in hen egg-white lysozyme in aqueous dimethylsulfoxide
16. Structural characterization of monellin in the alcohol-denatured state by NMR: Evidence for beta-sheet to alpha-helix conversion
17. Formation of tubules by a polymerizable surfactant
18. Lipid tubules: A paradigm for molecularly engineered structures
19. Thermodynamics of phospholipid tubules in alcohol/water solutions
20. Controlled release from cylindrical microstructures
21. Controlled release of transforming growth factor-beta from lipid-based microcylinders
22. Biologically engineering microstructures: Controlled release applications
23. Biocompatibility of lipid microcylinders: Effect on cell growth and antigen presentation in culture
24. The influence of physical structure and charge on neurite extension in a 3D hydrogel scaffold
25. Hydrogel-based three-dimensional matrix for neural cells
26. Interactions of sugars with membranes
27. Membrane stabilization during freezing: The role of two natural cryoprotectants, trehalose and proline
28. Bovine aortic endothelial cells elaborate an inhibitor of the generation of lipopolysaccharide-stimulated human blood monocyte procoagulant activity
29. Probing the structure of diacetylenic phospholipid tubules with fluorescent lipophiles
30. An in vitro bioassay for nerve growth factor based on 24-hour survival of PC-12 cells
31. A quantitative bioassay for nerve growth factor activity employing a clonal pheochromocytoma cell line
32. Bioassay detection of mouse nerve growth factor (mNGF) in the brain of adult mice
33. Nerve growth factor-induced process formation by cultured rat pheochromocytoma cells
34. In vivo biocompatibility of implantable delivery systems and biomaterials
35. Host response to tissue engineered devices